Fleming L, Murray C, Bansal AT, Hashimoto S, Bisgaard H, Bush A, et al. The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts. Eur Respir J. 2015;46(5):1322–33.

Article  CAS  PubMed  Google Scholar 

Moonie SA, Sterling DA, Figgs L, Castro M. Asthma status and severity affects missed school days. J Sch Health. 2006;76(1):18–24.

Article  PubMed  Google Scholar 

van den Bemt L, Kooijman S, Linssen V, Lucassen P, Muris J, Slabbers G, et al. How does asthma influence the daily life of children? Results of focus group interviews. Health Qual Life Outcomes. 2010;8:5.

Article  PubMed  PubMed Central  Google Scholar 

Montalbano L, Ferrante G, Montella S, Cilluffo G, Di Marco A, Bozzetto S, et al. Relationship between quality of life and behavioural disorders in children with persistent asthma: a Multiple Indicators Multiple Causes (MIMIC) model. Sci Rep. 2020;10(1):6957.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown HM, Storey G. Beclomethasone dipropionate steriod aerosol in treatment of perennial allergic asthma in children. Br Med J. 1973;3(5872):161–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kachroo P, Stewart ID, Kelly RS, Stav M, Mendez K, Dahlin A, et al. Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma. Nat Med. 2022;28(4):814–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Axelsson I, Naumburg E, Prietsch SO, Zhang L. Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth. Cochrane Database Syst Rev. 2019;6(6):Cd010126.

GINA Report. Global Strategy for Asthma Management and Prevention. Available at: http://www.ginasthma.org. 2022. Accessed August 2023.

Sweeney J, Patterson CC, Menzies-Gow A, Niven RM, Mansur AH, Bucknall C, et al. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry. Thorax. 2016;71(4):339–46.

Article  PubMed  Google Scholar 

Aljebab F, Choonara I, Conroy S. Systematic review of the toxicity of long-course oral corticosteroids in children. PLoS ONE. 2017;12(1): e0170259.

Article  PubMed  PubMed Central  Google Scholar 

Bush A, Fitzpatrick AM, Saglani S, Anderson WC, Szefler SJ. Difficult-to-treat asthma management in school-age children. J Allergy Clin Immunol Pract. 2022;10(2):359–75.

Article  PubMed  Google Scholar 

Bagnasco D, Paggiaro P, Latorre M, Folli C, Testino E, Bassi A, et al. Severe asthma: One disease and multiple definitions. World Allergy Organ J. 2021;14(11): 100606.

Article  PubMed  PubMed Central  Google Scholar 

Bousquet J, Mantzouranis E, Cruz AA, Aït-Khaled N, Baena-Cagnani CE, Bleecker ER, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010;126(5):926–38.

Article  PubMed  Google Scholar 

Bossley CJ, Fleming L, Ullmann N, Gupta A, Adams A, Nagakumar P, et al. Assessment of corticosteroid response in pediatric patients with severe asthma by using a multidomain approach. J Allergy Clin Immunol. 2016;138(2):413-20.e6.

Article  CAS  PubMed  Google Scholar 

Cook J, Beresford F, Fainardi V, Hall P, Housley G, Jamalzadeh A, et al. Managing the pediatric patient with refractory asthma: a multidisciplinary approach. J Asthma Allergy. 2017;10:123–30.

Article  PubMed  PubMed Central  Google Scholar 

US Food & Drug Administration. Drugs@FDA: FDA-Approved Drugs - Xolair. Available at: https://www.accessdata.fda.gov/SCRIPTS/CDER/DAF/index.cfm?event=overview.process&ApplNo=103976. Accessed August 2023.

Alizadeh Bahmani AH, Abdel-Aziz MI, Maitland-van der Zee AH, Vijverberg SJH. Recent advances in the treatment of childhood asthma: a clinical pharmacology perspective. Expert Rev Clin Pharmacol. 2022;15(10):1165–76.

Principe S, Vijverberg SJH, Abdel-Aziz MI, Scichilone N, Maitland-van der Zee AH. Precision medicine in asthma therapy. Handb Exp Pharmacol. 2022.

Golebski K, Dankelman LHM, Björkander S, Bønnelykke K, Brinkman P, Deschildre A, et al. Expert meeting report: towards a joint European roadmap to address the unmet needs and priorities of paediatric asthma patients on biologic therapy. ERJ Open Res. 2021;7(4).

Holguin F, Cardet JC, Chung KF, Diver S, Ferreira DS, Fitzpatrick A, et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. Eur Resp J. 2020;55(1).

Licari A, Manti S, Castagnoli R, Parisi GF, Salpietro C, Leonardi S, et al. Targeted therapy for severe asthma in children and adolescents: current and future perspectives. Paediatr Drugs. 2019;21(4):215–37.

Article  PubMed  Google Scholar 

Licari A, Castagnoli R, Marseglia A, Olivero F, Votto M, Ciprandi G, et al. Dupilumab to treat type 2 inflammatory diseases in children and adolescents. Paediatr Drugs. 2020;22(3):295–310.

Article  PubMed  Google Scholar 

Fleming L, Tsartsali L, Wilson N, Regamey N, Bush A. Sputum inflammatory phenotypes are not stable in children with asthma. Thorax. 2012;67(8):675–81.

Article  PubMed  Google Scholar 

Pijnenburg MW, Frey U, De Jongste JC, Saglani S. Childhood asthma: pathogenesis and phenotypes. Eur Resp J. 2022;59(6).

Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372(9643):1107–19.

Article  PubMed  Google Scholar 

Diamant Z, Vijverberg S, Alving K, Bakirtas A, Bjermer L, Custovic A, et al. Towards clinically applicable biomarkers for asthma—an EAACI position paper. Allergy. 2019.

Heijink IH, Kies PM, Kauffman HF, Postma DS, van Oosterhout AJ, Vellenga E. Down-regulation of E-cadherin in human bronchial epithelial cells leads to epidermal growth factor receptor-dependent Th2 cell-promoting activity. J Immunol. 2007;178(12):7678–85.

Article  CAS  PubMed  Google Scholar 

Wawrzyniak P, Wawrzyniak M, Wanke K, Sokolowska M, Bendelja K, Rückert B, et al. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients. J Allergy Clin Immunol. 2017;139(1):93–103.

Article  CAS  PubMed  Google Scholar 

Striz I, Golebski K, Strizova Z, Loukides S, Bakakos P, Hanania NA, et al. New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis. Clin Sci (Lond). 2023;137(9):727–53.

Article  CAS  PubMed  Google Scholar 

Golebski K, Röschmann KI, Toppila-Salmi S, Hammad H, Lambrecht BN, Renkonen R, et al. The multi-faceted role of allergen exposure to the local airway mucosa. Allergy. 2013;68(2):152–60.

Article  CAS  PubMed  Google Scholar 

Golebski K, Layhadi JA, Sahiner U, Steveling-Klein EH, Lenormand MM, Li RCY, et al. Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response. Immunity. 2021;54(2):291-307.e7.

Article  CAS  PubMed  Google Scholar 

van der Ploeg EK, Golebski K, van Nimwegen M, Fergusson JR, Heesters BA, Martinez-Gonzalez I, et al. Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases. Sci Immunol. 2021;6(55).

Marcos MC, Cisneros SC. What is the added value of FeNO as T2 biomarker? Front Allergy. 2022;3: 957106.

Article  PubMed  PubMed Central  Google Scholar 

Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol. 2002;109(3):410–8.

Article  CAS  PubMed  Google Scholar 

Comberiati P, Di Cicco ME, D’Elios S, Peroni DG. How much asthma is atopic in children? Front Pediatr. 2017;5:122.

Article  PubMed  PubMed Central  Google Scholar 

Hondowicz BD, An D, Schenkel JM, Kim KS, Steach HR, Krishnamurty AT, et al. Interleukin-2-dependent allergen-specific tissue-resident memory cells drive asthma. Immunity. 2016;44(1):155–66.

Article  CAS  PubMed  Google Scholar 

Bossley CJ, Fleming L, Gupta A, Regamey N, Frith J, Oates T, et al. Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. J Allergy Clin Immunol. 2012;129(4):974-82.e13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su MW, Lin WC, Tsai CH, Chiang BL, Yang YH, Lin YT, et al. Childhood asthma clusters reveal neutrophil-predominant phenotype with distinct gene expression. Allergy. 2018;73(10):2024–32.

Article  CAS  PubMed  Google Scholar 

Wisniewski JA, Muehling LM, Eccles JD, Capaldo BJ, Agrawal R, Shirley DA, et al. TH1 signatures are present in the lower airways of children with severe asthma, regardless of allergic status. J Allergy Clin Immunol. 2018;141(6):2048-60.e13.

Article  CAS  PubMed  Google Scholar 

Crisford H, Sapey E, Rogers GB, Taylor S, Nagakumar P, Lokwani R, et al. Neutrophils in asthma: the good, the bad and the bacteria. Thorax. 2021;76(8):835–44.

Article  PubMed  Google Scholar 

Moore WC, Hastie AT, Li X, Li H, Busse WW, Jarjour NN, et al. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol. 2014;133(6):1557-63.e5.

Article  PubMed  Google Scholar 

Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanović R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med. 2000;161(1):9–16.

Article  CAS  PubMed  Google Scholar 

Shaw DE, Berry MA, Hargadon B, McKenna S, Shelley MJ, Green RH, et al. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest. 2007;132(6):1871–5.

Article  CAS  PubMed  Google Scholar 

Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax. 2010;65(5):384–90.

Article  PubMed